Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of VirologicalFailure?
Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of VirologicalFailure?
Eva Poveda 1, Manuel Crespo 1
1 NULL
*Correspondence: Eva Poveda, Email not available
Abstract
The level of HIV-RNA in plasma (HIV viral load) is the main marker used to monitor the virological response to antiretroviral therapy (ART) in HIV-infected patients. The threshold used to define virological suppression has historically been dictated by the limits of detection of the commercial assays used to quantify the plasma viral load.
